Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Inhibin A

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 86336 refers to the measurement of inhibin A levels through a blood test. Inhibin A is a heterodimeric protein hormone that plays a significant role in reproductive health. It is secreted by granulosa cells in the ovaries of females and Sertoli cells in the testes of males. Additionally, during pregnancy, inhibin A is produced by the placenta. The levels of this hormone can fluctuate normally during specific phases of the female menstrual cycle and may also elevate during pregnancy. However, abnormal elevations of inhibin A can indicate various medical conditions, such as ovarian tumors, specifically granulosa cell tumors and epithelial mucinous-type tumors, as well as congenital abnormalities in the fetus, such as Down Syndrome. Furthermore, elevated levels may be associated with pregnancies complicated by preeclampsia. In clinical practice, when assessing fetal or pregnancy-related issues, the inhibin A test is often conducted alongside other tests, including alpha-fetoprotein (AFT), human chorionic gonadotropin (hCG), and Estriol, to provide a comprehensive evaluation. The blood sample for this test is obtained through venipuncture, which is a separately reportable procedure, and the serum is analyzed using quantitative chemiluminescent immunoassay techniques.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The inhibin A test (CPT® Code 86336) is indicated for several specific clinical scenarios, particularly in the context of reproductive health and prenatal screening. The following conditions and situations warrant the performance of this test:

  • Ovarian Tumors Abnormal elevations of inhibin A may indicate the presence of ovarian tumors, specifically granulosa cell tumors and epithelial mucinous-type tumors.
  • Congenital Abnormalities The test is utilized in the assessment of congenital abnormalities in the fetus, such as Down Syndrome, where abnormal levels of inhibin A may be detected.
  • Preeclampsia Elevated inhibin A levels can also be associated with pregnancies complicated by preeclampsia, making this test relevant in monitoring such conditions.
  • Fetal or Pregnancy-Related Problems The inhibin A test is often performed in conjunction with other tests to diagnose fetal or pregnancy-related issues, providing critical information for clinical decision-making.

2. Procedure

The procedure for measuring inhibin A levels involves several key steps that ensure accurate results. The following outlines the procedural steps involved:

  • Step 1: Patient Preparation Prior to the test, the patient may be advised on any necessary preparations, such as fasting or avoiding certain medications that could affect the results.
  • Step 2: Venipuncture A qualified healthcare professional performs venipuncture to obtain a blood sample from the patient. This step is crucial as it provides the serum needed for testing. The venipuncture procedure is separately reportable and must be documented appropriately.
  • Step 3: Serum Separation After collection, the blood sample is processed to separate the serum, which contains the inhibin A hormone. This step is essential for accurate measurement.
  • Step 4: Quantitative Chemiluminescent Immunoassay The serum is then subjected to a quantitative chemiluminescent immunoassay, a laboratory technique that allows for the precise measurement of inhibin A levels in the sample.
  • Step 5: Result Interpretation Once the testing is complete, the results are interpreted by a qualified healthcare provider, who will consider the inhibin A levels in conjunction with other clinical findings and tests.

3. Post-Procedure

After the inhibin A test is performed, there are several considerations for post-procedure care and follow-up. Patients may experience minor discomfort or bruising at the venipuncture site, which typically resolves quickly. It is important for healthcare providers to communicate the results of the test to the patient in a timely manner, especially if abnormal levels are detected. Follow-up testing or additional diagnostic procedures may be necessary based on the results of the inhibin A test, particularly if there are indications of ovarian tumors, congenital abnormalities, or complications such as preeclampsia. Patients should be advised to report any unusual symptoms or concerns following the test, and appropriate referrals to specialists may be warranted based on the findings.

Short Descr INHIBIN A
Medium Descr INHIBIN A
Long Descr Inhibin A
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 235 - Other Laboratory
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
GA Waiver of liability statement issued as required by payer policy, individual case
GC This service has been performed in part by a resident under the direction of a teaching physician
GZ Item or service expected to be denied as not reasonable and necessary
Date
Action
Notes
2002-01-01 Added First appearance in code book in 2002.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"